The Conference Forum Announces the launch of DPharm, the First Event on Disruptive Innovations in Clinical Trials

NEW YORK--(BUSINESS WIRE)-- The Conference Forum announced the launch of DPharm, Disruptive Innovations in Clinical Trials, the first event of its kind on transformative and disruptive approaches to advancing clinical trials. Led by Pfizer and Novartis, this conference is designed in a similar style to the TED events with a highly informative and engaging format.

“This conference is a unique opportunity for a community of leaders in our industry to explore, challenge and co-create bleeding-edge approaches in clinical research,” said Advisory Board member, Puneet Sapra, Director, World Wide Business Development & Innovation at Pfizer.

Several vital areas in clinical development will be addressed by disruptive thinkers who can impart their strategies on:

1. Challenges and Opportunities in Clinical Development
2. Innovations in Science Applied to Clinical Development
3. Innovations in Technology Applied to Clinical Development
4. New Business Models for Clinical Development

The speaking faculty includes:

Margaret A. Anderson
Executive Director
FasterCures/The Center for Accelerating Medical Solutions

Marc Cantillon, MD
Executive Director,
Coalition Against Major Diseases (CAMD)
Critical Path Institute (C-Path)

Sohini Chowdhury
Vice President, Research Partnerships
The Michael J. Fox Foundation for Parkinson’s Research

Kathleen Goin
Associate Director, Clinical Trial Manager
Endo Pharmaceuticals

Magali Haas, MD, PhD
Partner
Janssen R&D Innovation at Johnson & Johnson

Benjamin Heywood
Co-Founder, President and Director
PatientsLikeMe

Steve E. Labkoff, MD, FACP
Specialist Leader, Health Information Technology
AstraZeneca

Craig H. Lipset
Head of Clinical Innovation, Development Operations
Pfizer, Inc.

Jules T. Mitchel, MBA, PhD
President
Target Health Inc.

John Orloff, MD
Senior Vice President, Global Development & Chief Medical Officer
Novartis Pharma AG

Scott D. Patterson, PhD
Executive Director, Medical Sciences
Amgen Inc.

Jon Platt, MA Oxon
Leader, Healthcare Sector
?WHATIF! Innovation

Peter J. Pitts
President and Co-Founder
Center for Medicine in the Public Interest

Noah Rosenberg MD
Executive Medical Director, Head of Cardiovascular/Metabolism,
Clinical Development
Forest Research Institute

Tomasz Sablinski, PhD, MD
Managing Director
Celtic Therapeutics

Puneet Sapra, MBA
Director, World Wide Business Development & Innovation
Pfizer, Inc.

Diane Shoda
Director, Worldwide Regulatory Strategy,
Board Member NEWDIGS
Pfizer Inc.

Greg Simon
Senior Vice President Worldwide Policy
Pfizer

Bruce W. Turnbull, PhD, PStat
Professor of Statistics
Cornell University

The DPharm conference takes place September 15-16, 2011 at the Loews Hotel in Philadelphia, PA. For more information on the program case studies, please visit www.theconferenceforum.org or call 646 350 2580.



CONTACT:

The Conference Forum
Valerie Bowling, 646-350-2585
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Cardiology  Clinical Trials  Infectious Diseases  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.